EUVIMEDEUVIMED entdecken
Leserbrief

Selective JAK1 inhibition with upadacitinib controls STAT1 gain‐of‐function–related hidradenitis suppurativa and chronic mucocutaneous candidiasis

Robert Holden iD, Andrew Mclean-Tooke iD, Johnathan Chan, Michaela Lucas

Internal Medicine Journal · 2026-04 · 56 (4) · 722-724

DOI: 10.1111/imj.70399 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Internal Medicine Journal, online erschienen am 07.04.2026. Verfasst von Robert Holden und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Western Australia, Perth, Western Australia, Australia. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Department of Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Clinical Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Department of Immunology, PathWest, Perth, Western Australia, Australia.
  • Department of Dermatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Department of Immunology, Sir Charles Gairdner Hospital and Perth Children's Hospital, Perth, Western Australia, Australia.

ORCID-Profile: Robert Holden, Andrew Mclean-Tooke

Zitieren

APA

Holden, R., Mclean-Tooke, A., Chan, J., & Lucas, M. (2026). Selective JAK1 inhibition with upadacitinib controls STAT1 gain‐of‐function–related hidradenitis suppurativa and chronic mucocutaneous candidiasis. Internal Medicine Journal, 56(4), 722-724. https://doi.org/10.1111/imj.70399

Vancouver

Holden R, Mclean-Tooke A, Chan J, Lucas M. Selective JAK1 inhibition with upadacitinib controls STAT1 gain‐of‐function–related hidradenitis suppurativa and chronic mucocutaneous candidiasis. Internal Medicine Journal. 2026;56(4):722-724. doi:10.1111/imj.70399

BibTeX
@article{Holden2026,
  author = {Holden, Robert and Mclean-Tooke, Andrew and Chan, Johnathan and Lucas, Michaela},
  title = {Selective JAK1 inhibition with upadacitinib controls STAT1 gain‐of‐function–related hidradenitis suppurativa and chronic mucocutaneous candidiasis},
  journal = {Internal Medicine Journal},
  year = {2026},
  volume = {56},
  number = {4},
  pages = {722--724},
  doi = {10.1111/imj.70399}
}
Kostenlos starten →